Goldman Sachs
GS
$946.36
-0.22%
Goldman Sachs Group Inc. is a leading global financial institution operating primarily in the Financial - Capital Markets industry, with core businesses spanning investment banking, global markets trading, asset and wealth management, and lending. The firm is a dominant market leader, particularly in high-margin advisory services where it has been the top global M&A advisor by revenue for two decades, and has strategically expanded into more stable, fee-based businesses to diversify its revenue streams. The current investor narrative revolves around the firm's ability to navigate a volatile macroeconomic environment, with attention focused on the health of its capital markets activities, the growth trajectory of its asset and wealth management division, and its ongoing strategic pivot away from consumer banking initiatives.…
GS
Goldman Sachs
$946.36
Related headlines
Investment Opinion: Should I buy GS Today?
Rating: Hold. The core thesis is that Goldman Sachs is a high-quality franchise caught in a cyclical slowdown, trading at a reasonable but not compelling valuation, making it prudent to wait for a better entry point or clearer signs of fundamental acceleration.
The Hold rating is supported by a mixed data set: the forward PE of 14.51x and PEG ratio of 0.61 suggest undervaluation relative to growth, and analyst targets imply a +14.2% upside. However, this is counterbalanced by deteriorating quarterly revenue growth (-6.56% YoY), deeply negative free cash flow (-$47.22B TTM), and high financial leverage (D/E of 4.88). Profitability metrics like a 13.73% net margin are solid but not exceptional for the sector.
This Hold would upgrade to a Buy if the forward PE compressed below 13x (offering a larger margin of safety), quarterly revenue growth turns positive consecutively, or free cash flow shows sustained improvement. It would downgrade to a Sell if revenue decline accelerates beyond -10% YoY, the debt-to-equity ratio climbs above 5.5, or the stock breaks below key technical support around $850. Based on the current data, the stock appears fairly valued, pricing in a recovery but also acknowledging the near-term headwinds.
Sign up to view all
GS 12-Month Price Forecast
The 12-month outlook for GS is one of balanced uncertainty. The base case (50% probability) of range-bound trading is most likely, as the firm's powerful franchise and reasonable valuation provide a floor, while cyclical headwinds and cash flow concerns cap near-term upside. The bull case depends on a macro acceleration that is not currently in the data, while the bear case is a real risk given the firm's operational and financial leverage. The stance is neutral; developments that would prompt an upgrade to bullish include two consecutive quarters of positive revenue growth and a sustained improvement in free cash flow. A downgrade to bearish would be triggered by a break below $850 support or a quarterly net income decline exceeding 20%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Goldman Sachs's 12-month outlook, with a consensus price target around $1230.27 and implied upside of +30.0% versus the current price.
Average Target
$1230.27
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$757 - $1230
Analyst target range
Analyst coverage for Goldman Sachs appears limited in the provided data, with only 5 analysts cited, which is unusually low for a major financial institution and may indicate incomplete data capture. The consensus sentiment, inferred from recent institutional ratings, leans neutral to cautiously optimistic, with firms like JP Morgan at 'Neutral', RBC Capital at 'Sector Perform', and Wells Fargo and Barclays maintaining 'Overweight' ratings. The target price range, derived from estimated EPS, implies significant variance; using the average estimated EPS of $74.66 and the forward PE of 14.51x implies a consensus price target of approximately $1,083, representing a potential upside of +14.2% from the current price of $948.47, though the wide EPS range from $69.99 to $79.23 underscores the uncertainty in earnings projections and, by extension, valuation.
Bulls vs Bears: GS Investment Factors
The evidence for Goldman Sachs presents a nuanced picture where bullish fundamentals are tempered by significant cyclical and financial risks. The bull side currently holds a slight edge, anchored by a compelling valuation (PEG of 0.61, 14.2% analyst upside), strong long-term momentum, and the firm's unrivaled competitive moat. However, the bear case is formidable, highlighting severe cash flow consumption, revenue volatility, and high leverage. The single most important tension in the investment debate is the conflict between the stock's attractive growth-adjusted valuation and the deteriorating near-term fundamental picture (negative FCF, declining revenue). The thesis hinges on whether the market will continue to reward the long-term strategic pivot and market leadership, or if it will punish the near-term operational and financial metrics that are flashing warning signs.
Bullish
- Strong Analyst Upside Potential: The implied analyst consensus price target of approximately $1,083, based on average EPS and forward PE, offers a +14.2% upside from the current price. This target is supported by a forward PE of 14.51x, which is lower than the trailing PE, indicating expected earnings growth.
- Robust Long-Term Price Momentum: The stock has delivered a powerful 1-year price return of +54.0%, significantly outperforming the SPY's +25.19%. This sustained uptrend demonstrates strong market confidence in the firm's strategic direction and recovery trajectory.
- Dominant Market Position & Strategic Pivot: Goldman Sachs is the top global M&A advisor by revenue for two decades, securing high-margin advisory fees. Its strategic expansion into stable, fee-based asset and wealth management, now ~30% of revenue, diversifies earnings away from volatile trading.
- Attractive Valuation Relative to Growth: The PEG ratio of 0.61, calculated from the trailing PE of 16.00x and implied growth, suggests the stock is undervalued relative to its earnings growth prospects. This is a classic GARP (Growth at a Reasonable Price) signal.
Bearish
- Negative Free Cash Flow Raises Concern: The trailing-twelve-month free cash flow is a deeply negative -$47.22 billion. While typical for an investment bank due to trading/investment activities, it highlights cash intensity and reliance on favorable funding markets.
- Recent Revenue Volatility and Decline: Q4 2025 revenue of $30.125 billion declined -6.56% year-over-year, continuing a pattern of quarterly fluctuations. This underscores the inherent cyclicality and macro-sensitivity of its core capital markets businesses.
- High Leverage and Balance Sheet Risk: A debt-to-equity ratio of 4.88, while standard for the industry, signifies significant leverage. In a rising rate or risk-off environment, this amplifies financial risk and can pressure net interest margins.
- Technical Consolidation Near 52-Week High: Trading at 96% of its 52-week high ($984.7), the stock shows decelerating momentum (3-month gain of +4.79% vs. 1-year +54.0%). This suggests potential overextension and increased vulnerability to a pullback if it fails to break resistance.
GS Technical Analysis
The stock is in a sustained long-term uptrend, evidenced by a robust 1-year price change of +54.0%, but is currently consolidating after a significant rally. With a current price of $948.47, the stock is trading at approximately 96% of its 52-week high of $984.7, indicating it is near the top of its range; this positioning suggests strong momentum but also raises the risk of overextension and potential for a pullback if it fails to break through resistance. Recent momentum shows a deceleration, with a 1-month gain of +5.45% and a 3-month gain of +4.79%, both significantly trailing the 1-year performance, signaling a potential pause or consolidation phase within the broader uptrend. The stock's beta of 1.274 indicates it is approximately 27% more volatile than the broader market (SPY), which is a critical consideration for risk management, especially given the stock's proximity to its 52-week high and a recent maximum drawdown of -19.84%. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $984.7 and support at the 52-week low of $582.5; a decisive breakout above resistance would confirm the bullish trend's resumption, while a failure could lead to a test of lower support levels, with the recent drawdown highlighting the stock's inherent volatility.
Beta
1.27
1.27x market volatility
Max Drawdown
-19.8%
Largest decline past year
52-Week Range
$583-$985
Price range past year
Annual Return
+52.9%
Cumulative gain past year
| Period | GS Return | S&P 500 |
|---|---|---|
| 1m | +2.2% | +4.0% |
| 3m | +3.3% | +8.2% |
| 6m | +20.4% | +11.5% |
| 1y | +52.9% | +24.3% |
| ytd | +3.5% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GS Fundamental Analysis
Revenue growth has been inconsistent, with the most recent quarterly revenue of $30.125 billion representing a year-over-year decline of -6.56%, continuing a trend of volatility seen over recent quarters where revenue has fluctuated between $31.2 billion and $32.4 billion. The company remains solidly profitable, reporting net income of $4.617 billion for the quarter, with a gross margin of 51.71% and an operating margin of 17.47%; however, profitability metrics like net margin (13.73%) and ROE (13.74%), while positive, show room for improvement relative to peak periods. The balance sheet carries significant leverage with a debt-to-equity ratio of 4.88, which is typical for a major investment bank but necessitates careful monitoring, and free cash flow presents a concern with a trailing-twelve-month figure of -$47.218 billion, indicating substantial cash outflows likely tied to trading and investment activities rather than core operational weakness.
Quarterly Revenue
$30.1B
2025-12
Revenue YoY Growth
-0.06%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$-47.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GS Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 16.00x and a forward PE of 14.51x; the lower forward multiple suggests the market anticipates earnings growth, though the modest gap implies expectations are tempered. Compared to sector averages, Goldman Sachs's valuation appears mixed; its trailing PE of 16.00x is difficult to contextualize without a specific industry average, but its Price-to-Sales (PS) ratio of 2.20x and Price-to-Book (PB) ratio of 2.20x are key metrics for capital-intensive financial firms. Historically, the current trailing PE of 16.00x sits below the multi-year highs seen in recent quarters (e.g., 22.7x in mid-2023) but is above the lows near 8.4x from early 2022, placing it in a mid-range that suggests the market is pricing in a recovery but not peak-cycle optimism.
PE
16.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 4x~23x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
30.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company's negative TTM free cash flow of -$47.22 billion indicates massive cash outflows, primarily for trading positions and investments, making it vulnerable to liquidity squeezes. A debt-to-equity ratio of 4.88, while industry-typical, creates significant interest expense burden and refinancing risk in a volatile rate environment. Revenue concentration in cyclical capital markets activities was evident in the recent -6.56% YoY revenue decline, demonstrating earnings volatility that challenges consistent growth delivery.
Market & Competitive Risks center on valuation and macro-sensitivity. Trading at a forward PE of 14.51x, the valuation is not egregious, but the stock's proximity to its 52-week high (96%) leaves little margin for error and high risk of multiple compression if growth disappoints. The beta of 1.274 confirms high correlation to market swings, meaning a broad sell-off would disproportionately impact GS. Furthermore, the firm's strategic pivot to asset management faces intense competition from established giants, pressuring fee structures and growth.
Worst-Case Scenario involves a simultaneous macroeconomic downturn and capital markets freeze. This would trigger a severe decline in investment banking and trading revenue, exacerbate the negative free cash flow situation, and strain the highly leveraged balance sheet. Credit losses could rise in its lending book. In this adverse scenario, the stock could realistically revisit its 52-week low of $582.5, representing a downside of approximately -38.6% from the current price of $948.47. The recent -19.84% maximum drawdown provides a recent precedent for such volatility.
FAQ
The key risks, in order of severity, are: 1) Financial Risk: Massive negative free cash flow (-$47.22B TTM) and high leverage (D/E 4.88) create liquidity and refinancing vulnerability. 2) Cyclical Risk: Revenue is highly sensitive to capital markets activity, evidenced by the recent -6.56% YoY decline. 3) Market Risk: A beta of 1.274 means GS will fall more than the market in a downturn, as seen in its -19.84% max drawdown. 4) Execution Risk: The strategic pivot to asset management faces stiff competition and may not grow fast enough to offset core business volatility.
The 12-month forecast centers on a base case target range of $950-$1,080 (50% probability), anchored by the analyst-implied target of ~$1,083. The bull case (30% probability) sees a breakout to $1,150+ on a capital markets boom, while the bear case (20% probability) could see a decline to $700-$850 in a recessionary scenario. The most likely outcome is range-bound trading, as the stock digests its strong 1-year rally (+54%) amid mixed fundamental signals. The forecast hinges on the direction of quarterly revenue growth and free cash flow trends.
GS appears fairly valued to slightly undervalued based on growth expectations. The trailing PE of 16.00x is in the mid-range of its recent history, and the forward PE of 14.51x suggests the market is pricing in modest growth. The key metric is the PEG ratio of 0.61, which traditionally signals undervaluation relative to earnings growth potential. However, this must be weighed against the deteriorating near-term fundamentals. The valuation implies the market expects a recovery but is not willing to pay a premium for it until revenue growth turns sustainably positive.
GS presents a mixed opportunity. For investors seeking a high-quality financial franchise and who believe in a near-term recovery in capital markets, the +14.2% analyst upside and reasonable forward PE of 14.51x could be attractive. However, the significant risks—including negative free cash flow of -$47.22 billion, high leverage (D/E 4.88), and recent revenue decline—make it a higher-conviction Hold than a clear Buy at current levels. It is a good buy for patient, risk-tolerant investors willing to average in on weakness, but not for those seeking stable growth or low volatility.
GS is more suitable for a long-term (3+ year) investment horizon. Its business is cyclical, and realizing the full value of its strategic pivot to asset management requires time. The high beta (1.274) and recent volatility make it a challenging short-term trade. The modest 1.9% dividend yield does not support an income-focused strategy. Long-term investors can benefit from the firm's durable competitive advantages and eventual cyclical recovery, while weathering the interim volatility. A minimum holding period of 18-24 months is suggested to see through at least one full market cycle.
